drugset / Trial / NCT07166354

Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)

NCT07166354 ↗

Phase 1/2 Not yet recruiting 100 enrolled Applied Biology, Inc. Complex Science · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Clinical Study to Assess the Safety and Efficacy of CS-002 (mTOR inhibitor) as a treatment for Canities (Grey Hair)

Timeline

Start
2025-10-01
Primary completion
2027-06-15
Completion
2027-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject CS-002 Small molecule — Topical

Indications

No indication recorded.